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STUDY QUESTION: Can a consensus and evidence-driven set of terms and deﬁnitions be generated to be used globally in order to ensure
consistency when reporting on infertility issues and fertility care interventions, as well as to harmonize communication among the medical and
scientiﬁc communities, policy-makers, and lay public including individuals and couples experiencing fertility problems?
SUMMARY ANSWER: A set of 283 consensus-based and evidence-driven terminologies used in infertility and fertility care has been gener-
ated through an inclusive consensus-based process with multiple stakeholders.
WHAT IS KNOWN ALREADY: In 2006 the International Committee for Monitoring Assisted Reproductive Technologies (ICMART)
published a ﬁrst glossary of 53 terms and deﬁnitions. In 2009 ICMART together with WHO published a revised version expanded to 87
terms, which deﬁned infertility as a disease of the reproductive system, and increased standardization of fertility treatment terminology. Since
2009, limitations were identiﬁed in several areas and enhancements were suggested for the glossary, especially concerning male factor, dem-
ography, epidemiology and public health issues.
STUDY DESIGN, SIZE, DURATION: Twenty-ﬁve professionals, from all parts of the world and representing their expertise in a variety
of sub-specialties, were organized into ﬁve working groups: clinical deﬁnitions; outcome measurements; embryology laboratory; clinical and
laboratory andrology; and epidemiology and public health. Assessment for revisions, as well as expansion on topics not covered by the
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previous glossary, were undertaken. A larger group of independent experts and representatives from collaborating organizations further dis-
cussed and assisted in reﬁning all terms and deﬁnitions.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Members of the working groups and glossary co-ordinators interacted
through electronic mail and face-to-face in international/regional conferences. Two formal meetings were held in Geneva, Switzerland, with a
ﬁnal consensus meeting including independent experts as well as observers and representatives of international/regional scientiﬁc and patient
organizations.
MAIN RESULTS AND THE ROLE OF CHANCE: A consensus-based and evidence-driven set of 283 terminologies used in infertility
and fertility care was generated to harmonize communication among health professionals and scientists as well as the lay public, patients and
policy makers. Deﬁnitions such as ‘fertility care’ and ‘fertility awareness’ together with terminologies used in embryology and andrology have
been introduced in the glossary for the ﬁrst time. Furthermore, the deﬁnition of ‘infertility’ has been expanded in order to cover a wider spec-
trum of conditions affecting the capacity of individuals and couples to reproduce. The deﬁnition of infertility remains as a disease characterized
by the failure to establish a clinical pregnancy; however, it also acknowledges that the failure to become pregnant does not always result from
a disease, and therefore introduces the concept of an impairment of function which can lead to a disability. Additionally, subfertility is now
redundant, being replaced by the term infertility so as to standardize the deﬁnition and avoid confusion.
LIMITATIONS, REASONS FOR CAUTION: All stakeholders agreed to the vast majority of terminologies included in this glossary. In
cases where disagreements were not resolved, the ﬁnal decision was reached after a vote, deﬁned before the meeting as consensus if passed
with 75%. Over the following months, an external expert group, which included representatives from non-governmental organizations,
reviewed and provided ﬁnal feedback on the glossary.
WIDER IMPLICATIONS OF THE FINDINGS: Some terminologies have different deﬁnitions, depending on the area of medicine, for
example demographic or clinical as well as geographic differences. These differences were taken into account and this glossary represents a
multinational effort to harmonize terminologies that should be used worldwide.
STUDY FUNDING/COMPETING INTERESTS: None.
TRIAL REGISTRATION NUMBER: N/A.
Key words: glossary / terminologies / infertility / fertility care / ART
Introduction
Terms and deﬁnitions currently used in fertility care, infertility and
medically assisted reproduction (MAR) can have different meanings
that are dependent upon the setting, their usage in research or clinical
interventions, or among diverse populations. This can result in difﬁcul-
ties in standardizing and comparing fertility care interventions and their
outcomes, especially on a global level. Furthermore, the way some
terms are deﬁned can have an impact on their acceptance and under-
standing, not only by patients and their health care providers, but also
by the public and their policy makers, potentially affecting the manner
in which reproductive medicine is practiced and accepted at country
level. For example, in countries in which embryo cryopreservation is
forbidden by regulation or legislation, the distinction between a zygote
and an embryo can have enormous inﬂuence on clinical decision-
making such as the number of oocytes inseminated and/or the num-
ber of embryos transferred. Similarly, by deﬁning infertility as a disease
of the reproductive system (Zegers-Hochschild et al., 2009a, 2009b),
which can lead to disability, equity of access to fertility treatments has
been facilitated during debate and decision-making at regional and
national levels. These deﬁnitions helped to structure the debate con-
cerning key elements of sexual and reproductive rights within the deci-
sion by the Inter-American Court of Human Rights that resulted in
obliging Costa Rica to re-establish access to fertility care through ART
and ensure universal availability (Inter American Court of Human Rights,
2012). Therefore, an international consensus and evidence-driven set of
terms and deﬁnitions do beneﬁt communication of a common language
among scientiﬁc and clinical reproductive medicine communities, but
these also can have signiﬁcant impact on the understanding of the ﬁeld
which drives debate concerning overall access to reproductive health
care on a global level.
The ﬁrst international standardized deﬁnitions for reporting ART
procedures were published by the International Committee for
Monitoring Assisted Reproductive Technologies (ICMART) in 2006 as
The ICMART Glossary on ART Terminology (Zegers-Hochschild et al.,
2006a, 2006b). This document resulted from an ICMART initiative,
presented and documented within the meeting report entitled
Medical, Ethical and Social Aspects of Assisted Reproduction and published
by the World Health Organization (WHO), in 2002 (Vayena et al.,
2002). In 2008, the WHO together with ICMART, the Low-Cost IVF
Foundation and The International Federation of Fertility Societies
(IFFS) organized an international consensus consultation on ‘Assisted
Reproductive Technologies: Common Terminology and Management
in Low-Resource Settings’, again held at the WHO in Geneva,
Switzerland. The WHO was responsible for steering and management
of the consensus consultation, with expert technical lead provided
from ICMART, which resulted in the ﬁrst revision of the glossary. The
main terminology objective during the 2008 large consensus consult-
ation was to expand and improve on an internationally accepted set of
deﬁnitions that would help standardize and harmonize international
data collection in order to monitor the utilization, effectiveness, and
safety of ART interventions. In 2009, after review and approval
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through WHO processes, the glossary was published in English simultan-
eously in the journals Human Reproduction and Fertility and Sterility, and
was subsequently translated into Spanish and Portuguese (Red
Latinoamericana de Reproducción Asistida, 2010), Dutch (De Neubourg
et al., 2012), Japanese (Ishihara, 2010) and Russian (Korsak, 2011).
Working methodology
In December 2014, the WHO held an expert consultation to review
progress on its process of developing guidelines for infertility diagnosis,
management and treatment, assessing the available evidence through a
detailed systematic review process. During this consultation ICMART,
together with WHO and the other experts, agreed that the 2009
glossary be revised and expanded. This coincided with requests at
country level to address topic areas poorly represented in the previous
glossary, such as those associated with the male, and also to ﬁnd clarity
in terminologies used in infertility especially in the ﬁelds of epidemi-
ology, social science and global public health. This International
Glossary on Infertility and Fertility Care, 2017, is a consensus revision
to harmonize clinical practice and research, and to inform patients and
policy.
The revision process of the glossary since 2006 is described in Fig. 1.
To generate a revision of the 2009 glossary, the process began with
the selection and organization of 25 professionals, from different parts
of the world and representing a myriad of organizations covering vari-
ous sub-specialties, into ﬁve working groups according to their expert-
ise in: clinical deﬁnitions; outcome measurements; embryology
laboratory; clinical and laboratory andrology; and epidemiology and
public health. This need for a revision was also in response to a
requirement to better deﬁne terms associated with outcomes and
components that impact fertility treatments which include maternal
health risks as well as pregnancy and child outcomes. In 2014, the
WHO had participated in the modiﬁcation of the Consolidated
Standards of Reporting Trials (CONSORT), to ensure that the evi-
dence reported from clinical trials, or retrospectively from analysis of
clinic practice, would include maternal, neonate and child health out-
comes (IMPRINT), (Harbin Consensus Conference Workshop
Group, 2014a and Harbin Consensus Conference Workshop Group,
2014b). Thus, this 2017 glossary covers a broad spectrum of terms
currently being used in infertility and fertility care.
The responsibility of each working group was to review the existing
2009 deﬁnitions and to provide changes or to provide additional terms
in order to create the most accurate, current, evidence-based and
comprehensive glossary possible for this sector of reproductive health.
The lead experts of the glossary revision and the respective lead
experts from each of the glossary working groups interacted by elec-
tronic mail, at international and regional society meetings, and twice
attended consultations held in Geneva, Switzerland.
A consensus expert consultation meeting was held in September
2015. In order to reach agreement, a representative of each of the
working groups presented their set of draft terms and deﬁnitions to all
participants, which included experts in diverse ﬁelds as well as repre-
sentatives from patient groups. When disagreements were not
resolved, the ﬁnal decision was reached after a vote, deﬁned before
the meeting as consensus if passed with 75%. The vast majority of ter-
minologies included in this 2017 glossary were agreed upon during the
September, 2015 meeting. Adhering to internationally accepted pro-
cesses, over the next 9 months an external expert group, which
included representatives from non-governmental organizations,
reviewed and provided ﬁnal feedback on the glossary.
In addition to the lead organization (ICMART), professionals repre-
senting collaborative organizations included The American Society for
Reproductive Medicine (ASRM), ESHRE, the American College of
Obstetricians and Gynecologists (ACOG), the International Federation
of Gynecology and Obstetrics (FIGO), March of Dimes (MOD), the
International Federation of Fertility Societies (IFFS), Red Latinoamericana
de Reproducción Asistida (REDLARA), African Fertility Society, (AFS),
Groupe Inter-africain d’Etude de Recherche et d’Application sur la
Fertilité, (GIERAF), Asian Paciﬁc Initiative on Reproduction (ASPIRE),
and Middle East Fertility Society (MEFS). Also, organizations representing
infertile persons participated during the consensus meeting, which
included RESOLVE in the USA, TRASCENDER in Latin America, Joyce
Fertility in Uganda, and Fertility Europe, plus other infertile persons’
groups. In addition, representatives from the United Nations Population
Fund (UNFPA), Population Council, International Planned Parenthood
Federation (IPPF) and the Geneva Foundation for Medical Education and
Research (GFMER) also contributed to the consultation. The lead
experts of the evidence-synthesis groups who were developing and pre-
senting evidence for WHO guidelines also participated in the glossary
debates. Therefore, 108 international professional experts, including clin-
icians, basic scientists, epidemiologists and social scientists, along with
national and regional representatives of infertile persons, participated in
the development of this evidence-base driven glossary.
When developing terms and deﬁnitions, special attention was given
to possible impacts on ethics and human rights issues as well as recog-
nizing and respecting cultural sensitivities, ethnic minorities and gender
equality. Some of these considerations resulted in a consensus modiﬁ-
cation of the previous deﬁnition of ‘infertility’. The ﬁrst modiﬁcation
included broadening the concept of infertility to be an ‘impairment of
individuals’ in their capacity to reproduce, irrespective of whether
they have a partner. The revised deﬁnition also reinforces the con-
cept of infertility as a disease, which can generate an impairment of
function.
As part of a health-related international consensus and evidence-
driven process, certain terms and their deﬁnitions generated for the
glossary needed to be consistent with those existing and currently
used by the international fertility community and other international
organizations. This was the case when deciding at which gestational
age a miscarriage/abortion becomes a stillbirth, as it impacts individual
case documentation as well as subsequent calculations of miscarriage
and perinatal mortality rates, when reporting on outcomes of medic-
ally assisted reproduction (MAR) interventions and speciﬁcally of ART
either for registries or research.
Many terminologies carry different meanings and thus are repeat-
edly misused in the literature or social media. Such is the case with
the term ‘subfertility’. Consensus was reached that this term should
be used interchangeably with ‘infertility’. It was agreed that ‘subferti-
lity’ does not deﬁne a different or less severe fertility status than
infertility, nor is subfertility a condition that exists before infertility is
diagnosed. Furthermore, it is crucial to avoid the assumption that a
diagnosis of infertility implies sterility, instead the term ‘sterility’
should be used to deﬁne a permanent state of infertility. Thus, a
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2006: The ICMART Glossary on ART
Terminology
53 terms
2009, First revision: The ICMART/WHO
Revised Glossary on ART Terminology
87 terms
ICMART/WHO: Consensus consultaon on
“Assisted Reproducve Technologies: Common
Terminology and Management in Low-Resource
Sengs”. Geneva, Switzerland, 2008
“Medical, Ethical and Social Aspects of Assisted Reproducon” meeng.
Geneva, Switzerland, 2001
Three working groups:
- Clinical deﬁnions
- Laboratory procedures
- Outcome measures
WHO convener.
Non-Governmental
Organizaons:
- ICMART
- IFFS
- Low Cost IVF Foundaon
Five working groups1:
- Clinical deﬁnions
- Outcome measurements
- Embryology laboratory
- Clinical and laboratory
andrology
- Epidemiology and public
health
Parcipang organizaons2:
ACOG
AFS
ASPIRE
ASRM
ESHRE
Ferlity Europe
FIGO
GIERAF
GFMER
IFFS
ICMART
IPPF
Joyce Ferlity (Uganda)
March of Dimes
MEFS
Populaon Council
REDLARA
RESOLVE (USA)
TRASCENDER (Lan America)
UNFPA
2017, Second revision: The Internaonal Glossary
on Inferlity and Ferlity Care, 2017.
283 terms
Reassessment of the 2009 glossary:
- Side events at Internaonal and
Regional society meengs
-Two internaonal consultaons in
Geneva, Switzerland
-Final internaonal consensus
consultaon meeng. Geneva,
Switzerland. September, 2015
1Names of experts from each working group:
Clinical deﬁnions: Silke Dyer, Osamu Ishihara, Siladitya Bhaacharya, Adam Balen, Herman Tournaye, Paul Devroey, Bart C. Fauser.
Outcome measures: Jacques de Mouzon, Ragaa Mansour, Karl-Gösta Nygren, Elizabeth Sullivan, Anja Pinborg, Dolores Lamb.
Embryology laboratory; Clinical and laboratory andrology: Catherine Racowsky, Peter Nagy, Rebecca Sokol, Arne Sunde, Laura Rienzi,
Chris Barra, Lars Bjorndahl, Balaban Basak.
Epidemiology and public health: Ian D Cooke, Lone Schmidt, Cindy Farquhar, John Collins.
Coordinang team: Fernando Zegers-Hochschild, G. David Adamson, Sheryl van der Poel.
2Collaborave instuons and their representaves:
ACOG (Robert Rebar), AFS (Oladapo Ashiru, James Olalobo-Lalobo), ASPIRE (Jaideep Malhotra), ASRM (Richard Reindollar, Andrew La
Barbera), ESHRE (Kers Lundin, Roy Farquharson), Ferlity Europe (Anna Krawczack), FIGO (Gamal Serour, G. David Adamson), GIERAF
(Ernesne Gwet-Bell, Jacques de Mouzon), GFMER (Aldo Campana, Blaise Bourrit), IFFS (Richard Kennedy), ICMART, (G. David Adamson, Silke
Dyer), IPPF (Siri Tellier), Joyce Ferlity, Uganda (Rita Sembuya), March of Dimes (Joe Leigh Simpson), MEFS (Johnny Awwad, Michel Abou
Abdallah), Populaon Council (Patricia Morris, Sheryl van der Poel), REDLARA (Fernando Zegers-Hochschild), RESOLVE, USA (Barbara
Collura), Trascender, Lan America (Carmen Marnez), UNFPA (Luc de Bernis, Michaela Michel-Schuldt).
The experts menoned above, including addional experts and paent representaves aending the internaonal consensus consultaon,
represent all global geographic regions: Africa, Europe, Middle East, North and South America, South East Asia and the Western Paciﬁc.
Figure 1 Review process and methodology of the International Glossary on Infertility and Fertility Care, 2017. ICMART: International Committee
for Monitoring Assisted Reproductive Technologies; WHO: World Health Organization; IFFS: International Federation of Fertility Societies; ACOG:
American College of Obstetricians and Gynecologists; ASRM: American Society for Reproductive Medicine; IFFS: International Federation of Fertility
Societies; AFS: African Fertility Society; GFMER: Geneva Foundation for Medical Education and Research; GIERAF: Groupe Inter-africain d’Etude de
Recherche et d’Application sur la Fertilité; ASPIRE: Asian Paciﬁc Initiative on Reproduction; MEFS: Middle East Fertility Society; REDLARA: Red
Latinoamericana de Reproducción Asistida; FIGO: International Federation of Gynecology and Obstetrics; IPPF: International Planned Parenthood
Federation; UNFPA: United Nations Population Fund.
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consensus was reached that subfertility is a redundant term, and that
the term ‘infertility’ should be prioritized when providing an assess-
ment or diagnosis of an individual or couple. In a different context, a
consensus was also reached to remove from the glossary the term
‘conception’ and its derivatives such as conceiving or conceived,
because these are terms that cannot be described biologically during
the process of reproduction. Therefore, instead of using conception,
there was consensus that efforts should be made to use scientiﬁcally
recognized deﬁnitions such as fertilization, implantation, pregnancy
and live birth. It was also recognized that pregnancies do not ‘spon-
taneously’ happen, but rather an act of unprotected sexual inter-
course is required; thus, instead of the use of the term ‘spontaneous
pregnancies’ there was consensus that efforts should be made to use
the scientiﬁcally appropriate terms for pregnancies, either resulting
from medical assistance or without assistance.
Consensus terminologies associated with male aspects of infertility
were reached that include a clinical perspective as well as terminolo-
gies used in the andrology laboratory. Lastly, owing to the lack of
standardization in the determination of the burden of infertility, and to
better ensure comparability of prevalence data published globally, this
revised glossary includes deﬁnitions for terms frequently used in epi-
demiology and public health such as ‘voluntary and involuntary child-
lessness’, ‘primary and secondary infertility’, ‘fertility care’, ‘fecundity’
and ‘fecundability’ among others.
This glossary revision provides the medical and scientiﬁc communi-
ties, the lay public and policy-makers, as well as individuals and couples
experiencing fertility problems or infertility, with a consensus and
evidence-driven set of terms and deﬁnitions that can be used globally
to provide quality care and ensure consistency in registering speciﬁc
fertility care interventions plus more accurate reporting of their out-
comes on national, regional and international registries, and in social
media or results from research.
Results
Led by ICMART in partnership with ASRM, ESHRE, IFFS, MOD, AFS,
GIERAF, ASPIRE, MEFS, REDLARA and FIGO, consensus agreement
was reached by a global representation of multi-disciplinary experts
and patient representatives on 283 terms and deﬁnitions which are
listed in alphabetical order.
.............................................................................................................................................................................................
The International Glossary on Infertility and Fertility Care, 2017
Term Consensus deﬁnition
Acrosome A membrane-bound structure covering the anterior of the sperm head that contains enzymes necessary
to penetrate the zona pellucida of the oocyte.
Adenomyosis A form of endometriosis marked by the presence of endometrium-like epithelium and stroma outside
the endometrium in the myometrium.
Adhesions Bands of ﬁbrous scar tissue that may bind the abdominal and pelvic organs, including the intestines and
peritoneum, to each other. They can be dense and thick or ﬁlmy and thin.
Age speciﬁc fertility rate (ASFR) The number of live births per woman in a particular age group in a speciﬁc calendar year expressed per
1000 women in that age group.
Agglutination Clumping of spermatozoa in the ejaculate.
Andrology The medical practice dealing with the health of the male reproductive system.
Aneuploidy An abnormal number of chromosomes in a cell. The majority of embryos with aneuploidies are not
compatible with life.
Anti-sperm antibodies Antibodies that recognize and bind to antigens on the surface of the spermatozoon.
Aspermia Lack of external ejaculation.
Assisted hatching An ART procedure in which the zona pellucida of an embryo is either thinned or perforated by chemical,
mechanical or laser methods.
Assisted reproductive technology (ART) All interventions that include the in vitro handling of both human oocytes and sperm or of embryos for the
purpose of reproduction. This includes, but is not limited to, IVF and embryo transfer ET,
intracytoplasmic sperm injection ICSI, embryo biopsy, preimplantation genetic testing PGT, assisted
hatching, gamete intrafallopian transfer GIFT, zygote intrafallopian transfer, gamete and embryo
cryopreservation, semen, oocyte and embryo donation, and gestational carrier cycles. Thus, ART does
not, and ART-only registries do not, include assisted insemination using sperm from either a woman’s
partner or a sperm donor. (See broader term, medically assisted reproduction, MAR.)
Asthenoteratozoospermia Reduced percentages of motile and morphologically normal sperm in the ejaculate below the lower
reference limit. When reporting results, the reference criteria should be speciﬁed.
Asthenozoospermia Reduced percentage of motile sperm in the ejaculate below the lower reference limit. When reporting
results, the reference criteria should be speciﬁed.
Azoospermia The absence of spermatozoa in the ejaculate.
Binucleation The presence of two nuclei in a blastomere (cell).
Continued
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Continued
Term Consensus deﬁnition
Biochemical pregnancy A pregnancy diagnosed only by the detection of beta hCG in serum or urine.
Birth (single) The complete expulsion or extraction from a woman of a fetus after 22 completed weeks of gestational
age, irrespective of whether it is a live birth or stillbirth, or, if gestational age is unknown, a birth weight
more than 500 grams. A single birth refers to an individual newborn; and a delivery of multiple births,
such as a twin delivery, would be registered as two births.
Blastocoele Fluid-ﬁlled central region of the blastocyst.
Blastocyst The stage of preimplantation embryo development that occurs around day 5–6 after insemination or
ICSI. The blastocyst contains a ﬂuid ﬁlled central cavity (blastocoele), an outer layer of cells
(trophectoderm) and an inner group of cells (inner cell mass).
Blastomere A cell in a cleavage stage embryo.
Blastomere symmetry The extent to which all blastomeres are even in size and shape.
Bleeding after oocyte aspiration Signiﬁcant bleeding, internal or external, after oocyte aspiration retrieval requiring hospitalization for
blood transfusion, surgical intervention, clinical observation or other medical procedure.
Canceled ART cycle An ART cycle in which ovarian stimulation or monitoring has been initiated with the intention to treat,
but which did not proceed to follicular aspiration or in the case of a thawed or warmed embryo did not
proceed to embryo transfer.
Childlessness A condition in which a person, voluntarily or involuntarily, is not a legal or societally-recognized parent to
a child, or has had all children die.
Chimerism Presence in a single individual of two or more cell lines, each derived from different individuals.
Cleavage stage embryos Embryos beginning with the 2-cell stage and up to, but not including, the morula stage.
Clinical fertility The capacity to establish a clinical pregnancy.
Clinical pregnancy A pregnancy diagnosed by ultrasonographic visualization of one or more gestational sacs or deﬁnitive
clinical signs of pregnancy. In addition to intra-uterine pregnancy, it includes a clinically documented
ectopic pregnancy.
Clinical pregnancy rate The number of clinical pregnancies expressed per 100 initiated cycles, aspiration cycles or embryo
transfer cycles. When clinical pregnancy rates are recorded, the denominator (initiated, aspirated or
embryo transfer cycles) must be speciﬁed.
Clinical pregnancy with fetal heart beat A pregnancy diagnosed by ultrasonographic or clinical documentation of at least one fetus with a
discernible heartbeat.
Cohort total fertility rate (CTFR) The observed average number of live born children per woman applied to a birth cohort of women as they
age through time. This is obtained from data on women after completing their reproductive years.
Compaction The process during which tight junctions form between juxtaposed blastomeres resulting in a solid mass
of cells with indistinguishable cell membranes.
Complex aneuploidies Two or more aneuploidies involving different chromosomes in the embryo. When autosomes are
involved, this condition is not compatible with human life.
Congenital anomalies Structural or functional disorders that occur during intra-uterine life and can be identiﬁed prenatally, at
birth or later in life. Congenital anomalies can be caused by single gene defects, chromosomal disorders,
multifactorial inheritance, environmental teratogens and micronutrient deﬁciencies. The time of
identiﬁcation should be reported.
Congenital anomaly birth rate The number of births exhibiting signs of congenital anomalies per 10,000 births. The time of identiﬁcation
should have been reported.
Congenital bilateral absence of the vasa deferentia
(CBAVD)
The absence, at birth, of both duct systems (vas deferentia) that connect the testes to the urethra and
may be associated with cystic ﬁbrosis transmembrane conductance regulator (CTFR) gene mutation.
Although the testes usually develop and function normally, men present with azoospermia.
Conventional in vitro insemination The co-incubation of oocytes with sperm in vitro with the goal of resulting in extracorporeal fertilization.
Corona radiata cells The innermost cells of the cumulus oophorus.
Cross border reproductive care The provision of reproductive health services in a different jurisdiction or outside of a recognized national
border within which the person or persons legally reside.
Cryopreservation The process of slow freezing or vitriﬁcation to preserve biological material (e.g. gametes, zygotes,
cleavage-stage embryos, blastocysts or gonadal tissue) at extreme low temperature.
Cryptorchidism Testis not in scrotal position within the neonatal period and, up to but not limited to, 1 year post birth. If
the testis has not descended into the scrotum, this condition can cause primary testicular failure and
increased risk of testicular cancer development.
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Cumulative delivery rate per aspiration/initiated
cycle with at least one live birth
The number of deliveries with at least one live birth resulting from one initiated or aspirated ART cycle,
including all cycles in which fresh and/or frozen embryos are transferred, until one delivery with a live
birth occurs or until all embryos are used, whichever occurs ﬁrst. The delivery of a singleton, twin, or
other multiples is registered as one delivery. In the absence of complete data, the cumulative delivery
rate is often estimated.
Cumulus oophorus The multi-layered mass of granulosa cells surrounding the oocyte.
Cytoplasmic maturation The process during which the oocyte acquires the capacity to support nuclear maturation, fertilization,
pronuclei formation, syngamy and subsequent early cleavage divisions until activation of the embryonic
genome.
Cytoplasmic transfer A procedure that can be performed at different stages of an oocyte’s development to add to or replace
various amounts of cytoplasm from a donor egg.
Decreased spermatogenesis A histological ﬁnding in which spermatogenesis is present with few cells in the seminiferous tubules,
resulting in a decreased number or absence of sperm in the ejaculate.
Delayed ejaculation A condition in which it takes a man an extended period of time to reach orgasm and ejaculation.
Delayed embryo transfer A procedure in which embryo transfer is not performed within the time frame of the oocyte aspiration
cycle but at a later time.
Delivery The complete expulsion or extraction from a woman of one or more fetuses, after at least 22 completed
weeks of gestational age, irrespective of whether they are live births or stillbirths. A delivery of either a
single or multiple newborn is considered as one delivery. If more than one newborn is delivered, it is
often recognized as a delivery with multiple births.
Delivery rate The number of deliveries expressed per 100 initiated cycles, aspiration cycles, or embryo transfer cycles.
When delivery rates are recorded, the denominator (initiated, aspirated or embryo transfer cycles) must
be speciﬁed. It includes deliveries that resulted in the birth of one or more live births and/or stillbirths.
The delivery of a singleton, twin or other multiple pregnancy is registered as one delivery. If more than
one newborn is delivered, it is often recognized as a delivery with multiple births.
Delivery rate after fertility treatment per patient The number of deliveries with at least one live birth or stillbirth, expressed per 100 patients, after a
speciﬁed time and following all treatments.
Delivery with multiple births after fertility
treatments
A single delivery with more than one newborn, following all fertility treatments.
Diandric oocytes An oocyte with an extra set of haploid chromosomes of paternal origin.
Digynic oocytes An oocyte with an extra set of haploid chromosomes of maternal origin.
Diminished ovarian reserve A term generally used to indicate a reduced number and/or reduced quality of oocytes, such that the
ability to reproduce is decreased. (See ovarian reserve.)
Diploidy/euploidy The condition in which a cell has two haploid sets of chromosomes. Each chromosome in one set is
paired with its counterpart in the other set. A diploid embryo has 22 pairs of autosomes and two sex
chromosomes, the normal condition.
Disomy The normal number of chromosomes characterized by 22 pairs of autosomal chromosomes and one pair
of sex chromosomes (XX or XY). The chromosome number in human cells is normally 46.
Donor insemination The process of placing laboratory processed sperm or semen from a man into the reproductive tract of a
woman who is not his intimate sexual partner, for the purpose of initiating a pregnancy.
Double embryo transfer (DET) The transfer of two embryos in an ART procedure. This may be elective (eDET) when more than two
embryos of sufﬁcient quality for transfer are available.
Early neonatal death/mortality Death of a newborn within 7 days of birth.
Ectopic pregnancy A pregnancy outside the uterine cavity, diagnosed by ultrasound, surgical visualization or histopathology.
Ejaculation Co-ordinated contractions of the genitourinary tract leading to the ejection of spermatozoa and seminal
ﬂuid.
Ejaculation retardata A condition resulting in an inability to ejaculate during vaginal intercourse.
Ejaculatory duct The canal that passes through the prostate just lateral to the verumontanum where the vas deferens and
the duct from the seminal vesicle coalesce.
Elective embryo transfer The transfer of one or more embryos, selected from a larger cohort of available embryos.
Elective single embryo transfer (eSET) The transfer of one (a single) embryo selected from a larger cohort of available embryos.
Embryo The biological organism resulting from the development of the zygote, until eight completed weeks after
fertilization, equivalent to 10 weeks of gestational age.
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Embryo bank Repository of cryopreserved embryos stored for future use.
Embryo donation (for reproduction) An ART cycle, which consists of the transfer of an embryo to the uterus or Fallopian tube of a female
recipient, resulting from gametes that did not originate from the female recipient or from her male
partner, if present.
Embryo fragmentation The process during which one or more blastomeres shed membrane vesicles containing cytoplasm and
occasionally whole chromosomes or chromatin.
Embryo recipient cycle An ART cycle in which a woman’s uterus is prepared to receive one or more cleavage stage embryos/
blastocysts, resulting from gametes that did not originate from her or from her male partner, if present.
Embryo transfer (ET) Placement into the uterus of an embryo at any embryonic stage from day 1 to day 7 after IVF or ICSI.
Embryos from day 1 to day three can also be transferred into the Fallopian tube.
Embryo transfer cycle An ART cycle in which one or more fresh or frozen/thawed embryos at cleavage or blastocyst stage are
transferred into the uterus or Fallopian tube.
Emission (semen) Co-ordinated contractions of the vas deferentia, seminal vesicles, and ejaculatory ducts leading to
deposition of semen into the urethral meatus prior to ejaculation.
Endometriosis A disease characterized by the presence of endometrium-like epithelium and stroma outside the
endometrium and myometrium. Intrapelvic endometriosis can be located superﬁcially on the peritoneum
(peritoneal endometriosis), can extend 5 mm or more beneath the peritoneum (deep endometriosis) or
can be present as an ovarian endometriotic cyst (endometrioma).
Epididymis A convoluted, highly coiled duct that transports the spermatozoa from the testis via the efferent ducts to
the vas deferens.
Erectile dysfunction Inability to have and/or sustain an erection sufﬁcient for intercourse.
Euploidy The condition in which a cell has chromosomes in an exact multiple of the haploid number; in the human
this multiple is normally two. Thus, a normal embryo that is euploid is also diploid.
Excessive ovarian response An exaggerated response to ovarian stimulation characterized by the presence of more follicles than
intended. Generally, more than 20 follicles >12 mm in size and/or more than 20 oocytes collected
following ovarian stimulation are considered excessive, but these numbers are adaptable according to
ethnic and other variables.
Expectant fertility management Management of fertility problems including infertility without any speciﬁc active clinical or therapeutic
interventions other than fertility information and advice, to improve natural fertility, based upon the
probability of becoming pregnant.
Extremely low birth weight Birth weight less than 1000 g.
Extremely preterm birth A birth that takes place after 22 but before 28 completed weeks of gestational age.
Fecundability The probability of a pregnancy, during a single menstrual cycle in a woman with adequate exposure to
sperm and no contraception, culminating in a live birth. In population-based studies, fecundability is
frequently measured as the monthly probability.
Fecundity Clinically deﬁned as the capacity to have a live birth.
Female infertility Infertility caused primarily by female factors encompassing: ovulatory disturbances; diminished ovarian
reserve; anatomical, endocrine, genetic, functional or immunological abnormalities of the reproductive
system; chronic illness; and sexual conditions incompatible with coitus.
Fertility The capacity to establish a clinical pregnancy.
Fertility awareness The understanding of reproduction, fecundity, fecundability, and related individual risk factors (e.g.
advanced age, sexual health factors such as sexually transmitted infections, and life style factors such as
smoking, obesity) and non-individual risk factors (e.g. environmental and work place factors); including
the awareness of societal and cultural factors affecting options to meet reproductive family planning, as
well as family building needs.
Fertility care Interventions that include fertility awareness, support and fertility management with an intention to assist
individuals and couples to realize their desires associated with reproduction and/or to build a family.
Fertility preservation Various interventions, procedures and technologies, including cryopreservation of gametes, embryos or
ovarian and testicular tissue to preserve reproductive capacity.
Fertilization A sequence of biological processes initiated by entry of a spermatozoon into a mature oocyte followed
by formation of the pronuclei.
Fetal loss Death of a fetus. It is referred to as early fetal loss when death takes place between 10 and 22 weeks of
gestational age; late fetal loss, when death takes place between 22 and 28 weeks of gestational age; and
stillbirth when death takes place after 28 weeks gestational age.
Continued
1793Glossary on Infertility and Fertility Care, 2017
Downloaded from https://academic.oup.com/humrep/article-abstract/32/9/1786/4049537
by Kobenhavns Universitets user
on 01 May 2018
.............................................................................................................................................................................................
Continued
Term Consensus deﬁnition
Fetus The stages of development of an organism from eight completed weeks of fertilization (equivalent to 10
weeks of gestational age) until the end of pregnancy
Freeze-all cycle An ART cycle in which, after oocyte aspiration, all oocytes and/or embryos are cryopreserved and no
oocytes and/or embryos are transferred to a woman in that cycle.
Frozen-thawed embryo transfer (FET) cycle An ART procedure in which cycle monitoring is carried out with the intention of transferring to a woman,
frozen/thawed or vitriﬁed/warmed embryo(s)/blastocyst(s). Note: A FET cycle is initiated when speciﬁc
medication is provided or cycle monitoring is started in the female recipient with the intention to transfer
an embryo.
Frozen-thawed oocyte cycle An ART procedure in which cycle monitoring is carried out with the intention of fertilizing thawed/
warmed oocytes and performing an embryo transfer.
Full-term birth A birth that takes place between 37 and 42 completed weeks of gestational age.
Gamete intrafallopian transfer (GIFT) An ART procedure in which both gametes (oocytes and spermatozoa) are transferred into a Fallopian
tube(s).
Germinal vesicle (GV) The nucleus in an oocyte at prophase I.
Gestational age The age of an embryo or fetus calculated by the best obstetric estimate determined by assessments
which may include early ultrasound and the date of the last menstrual period and/or perinatal details. In
the case of ART, it is calculated by adding two weeks (14 days) to the number of completed weeks since
fertilization. Note: For frozen-thawed embryo transfer (FET) cycles, an estimated date of fertilization is
computed by subtracting the combined number of days an embryo was in culture pre-cryopreservation
and post-thaw/-warm, from the transfer date of the FET cycle.
Gestational carrier A woman who carries a pregnancy with an agreement that she will give the offspring to the intended
parent(s). Gametes can originate from the intended parent(s) and/or a third party (or parties). This
replaces the term ‘surrogate.’
Gestational sac A ﬂuid-ﬁlled structure associated with early pregnancy, which may be located inside or, in the case of an
ectopic pregnancy, outside the uterus.
Globozoospermia Describes spermatozoa with a reduced or absent acrosome.
Haploidy The condition in which a cell has one set of each of the 23 single chromosomes. Mature human gametes
are haploid, each having 23 single chromosomes.
Hatching The process by which an embryo at the blastocyst stage extrudes out of, and ultimately separates from,
the zona pellucida.
Heterotopic pregnancy Concurrent pregnancy involving at least one embryo implanted in the uterine cavity and at least one
implanted outside of the uterine cavity.
High-order multiple births The complete expulsion or extraction from their mother of three or more fetuses, after 22 completed
weeks of gestational age, irrespective of whether they are live births or stillbirths.
High-order multiple gestation A pregnancy with three or more embryos or fetuses.
Hydrosalpinx A distally occluded, dilated, ﬂuid-ﬁlled Fallopian tube.
Hypergonadotropic hypogonadism Gonadal failure associated with reduced gametogenesis, reduced gonadal steroid production and
elevated gonadotropin production.
Hyperspermia High volume of ejaculate above the upper reference limit. When reporting results, the reference criteria
should be speciﬁed.
Hypogonadotropic hypogonadism Gonadal failure associated with reduced gametogenesis and reduced gonadal steroid production due to
reduced gonadotropin production or action.
Hypospermatogenesis Histopathologic description of reduced production of spermatozoa in the testes.
Hypospermia Low volume of ejaculate below the lower reference limit. When reporting results, the reference criteria
should be speciﬁed.
Iatrogenic testicular failure Damage to testicular function after radiation, chemotherapy or hormone treatment; or devascularization
as a consequence of hernia surgery.
Immature oocyte An oocyte at prophase of meiosis I, (i.e. an oocyte at the germinal vesicle (GV)-stage.)
Implantation The attachment and subsequent penetration by a zona-free blastocyst into the endometrium, but when it
relates to an ectopic pregnancy, into tissue outside the uterine cavity. This process starts 5 to 7 days after
fertilization of the oocyte usually resulting in the formation of a gestation sac.
Implantation rate The number of gestational sacs observed divided by the number of embryos transferred (usually
expressed as a percentage, %).
Continued
1794 Zegers-Hochschild et al.
Downloaded from https://academic.oup.com/humrep/article-abstract/32/9/1786/4049537
by Kobenhavns Universitets user
on 01 May 2018
.............................................................................................................................................................................................
Continued
Term Consensus deﬁnition
In vitro fertilization (IVF) A sequence of procedures that involves extracorporeal fertilization of gametes. It includes conventional
in vitro insemination and ICSI.
In vitromaturation (IVM) A sequence of laboratory procedures that enable extracorporeal maturation of immature oocytes into
fully mature oocytes that are capable of being fertilized with potential to develop into embryos.
Induced abortion Intentional loss of an intrauterine pregnancy, through intervention by medical, surgical or unspeciﬁed
means. (See induced embryo/fetal reduction.)
Induced embryo/fetal reduction An intervention intended to reduce the number of gestational sacs or embryos/fetuses in a multiple
gestation.
Infertility A disease characterized by the failure to establish a clinical pregnancy after 12 months of regular,
unprotected sexual intercourse or due to an impairment of a person’s capacity to reproduce either as an
individual or with his/her partner. Fertility interventions may be initiated in less than 1 year based on
medical, sexual and reproductive history, age, physical ﬁndings and diagnostic testing. Infertility is a
disease, which generates disability as an impairment of function.
Infertility counseling A professional intervention with the intention to mitigate the physical, emotional and psychosocial
consequences of infertility.
Initiated medically assisted reproduction cycle
(iMAR)
A cycle in which the woman receives speciﬁc medication for ovarian stimulation or in which cycle
monitoring is carried out with the intention to treat, irrespective of whether or not insemination is
performed, follicular aspiration is attempted in an ovarian stimulation cycle or whether egg(s) or embryo
(s) are thawed or transferred in a frozen embryo transfer (FET) cycle.
Inner cell mass A group of cells attached to the polar trophectoderm consisting of embryonic stem cells, which have the
potential to develop into cells and tissues in the human body, except the placenta or amniotic membranes.
Intended parent(s) A couple or person who seek(s) to reproduce with the assistance of a gestational carrier or traditional
gestational carrier.
Intra-cervical insemination A procedure in which laboratory processed sperm are placed in the cervix to attempt a pregnancy.
Intracytoplasmic sperm injection (ICSI) A procedure in which a single spermatozoon is injected into the oocyte cytoplasm.
Intra-uterine insemination A procedure in which laboratory processed sperm are placed in the uterus to attempt a pregnancy.
Intra-uterine pregnancy A state of reproduction in which an embryo has implanted in the uterus.
Laparoscopic ovarian drilling A surgical method for inducing ovulation in females with anovulatory or oligo-ovulatory polycystic ovarian
syndrome, utilizing either laser or electrosurgery.
Large for gestational age A birth weight greater than the 90th centile of the sex-speciﬁc birth weight for a given gestational age
reference. When reporting outcomes, the reference criteria should be speciﬁed. If gestational age is
unknown, then the birth weight should be registered.
Leukospermia A high number of white blood cells in semen above the upper reference limit. When reporting results,
the reference criteria should be speciﬁed.
Leydig cell Type of testicular cell located in the interstitial space between the seminiferous tubules, that secretes
testosterone.
Live birth The complete expulsion or extraction from a woman of a product of fertilization, after 22 completed
weeks of gestational age; which, after such separation, breathes or shows any other evidence of life, such
as heart beat, umbilical cord pulsation or deﬁnite movement of voluntary muscles, irrespective of
whether the umbilical cord has been cut or the placenta is attached. A birth weight of 500 grams or more
can be used if gestational age is unknown. Live births refer to the individual newborn; for example, a twin
delivery represents two live births.
Live birth delivery rate The number of deliveries that resulted in at least one live birth, expressed per 100 cycle attempts. In the
case of ART/MAR interventions, they can be initiated cycles, insemination, aspiration cycles or embryo
transfer cycles. When delivery rates are given, the denominator (initiated, inseminated, aspirated or
embryo transfer cycles) must be speciﬁed.
Low birth weight Birth weight less than 2500 g.
Luteal phase defect A poorly deﬁned abnormality of the endometrium presumably due to abnormally low progesterone
secretion or action on the endometrium.
Luteal phase support Hormonal supplementation in the luteal phase, usually progesterone.
Major congenital anomaly A congenital anomaly that requires surgical repair of a defect, is a visually evident or life-threatening
structural or functional defect, or causes death.
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Male infertility Infertility caused primarily by male factors encompassing: abnormal semen parameters or function;
anatomical, endocrine, genetic, functional or immunological abnormalities of the reproductive system;
chronic illness; and sexual conditions incompatible with the ability to deposit semen in the vagina.
Maternal spindle transfer Transfer of the maternal spindle (including maternal chromosomes) from a patient’s oocyte into a
donated oocyte in which the maternal spindle with chromosomes has been removed.
Mature oocyte An oocyte at metaphase of meiosis II, exhibiting the ﬁrst polar body and with the ability to become
fertilized.
Maturing oocyte An oocyte that has progressed from prophase I but has not completed telophase I, thus does not exhibit
the ﬁrst polar body.
Medically assisted reproduction (MAR) Reproduction brought about through various interventions, procedures, surgeries and technologies to
treat different forms of fertility impairment and infertility. These include ovulation induction, ovarian
stimulation, ovulation triggering, all ART procedures, uterine transplantation and intra-uterine,
intracervical and intravaginal insemination with semen of husband/partner or donor.
Microdissection testicular sperm extraction
(MicroTESE)
A surgical procedure using an operating microscope to identify seminiferous tubules that may contain
sperm to be extracted for IVF and/or ICSI.
Micromanipulation in ART A micro-operative ART procedure performed on sperm, egg or embryo; the most common ART
micromanipulation procedures are ICSI, assisted hatching and gamete or embryo biopsy for PGT.
Microsurgical epididymal sperm aspiration/
extraction (MESA/MESE)
A surgical procedure performed with the assistance of an operating microscope to retrieve sperm from
the epididymis of men with obstructive azoospermia. In the absence of optical magniﬁcation, any surgical
procedure to retrieve sperm from the epididymis should also be registered as MESE.
Mild ovarian stimulation for IVF A protocol in which the ovaries are stimulated with gonadotropins, and/or other pharmacological
compounds, with the intention of limiting the number of oocytes following stimulation for IVF.
Missed spontaneous abortion/missed miscarriage Spontaneous loss of a clinical pregnancy before 22 completed weeks of gestational age, in which the
embryo(s) or fetus(es) is/are nonviable and is/are not spontaneously absorbed or expelled from the
uterus.
Modiﬁed natural cycle An ART procedure in which one or more oocytes are collected from the ovaries during a spontaneous
menstrual cycle. Pharmacological compounds are administered with the sole purpose of blocking the
spontaneous LH surge and/or inducing ﬁnal oocyte maturation.
Monosomy The absence of one of the two homologous chromosomes in embryos. Autosomal monosomies in
embryos are not compatible with life. Embryos with sex chromosome monosomies are rarely compatible
with life.
Morula An embryo formed after completion of compaction, typically 4 days after insemination or ICSI.
Mosaicism A state in which there is more than one karyotypically distinct cell population arising from a single
embryo.
Multinucleation The presence of more than one nucleus in a cell.
Multiple birth The complete expulsion or extraction from a woman of more than one fetus, after 22 completed weeks
of gestational age, irrespective of whether it is a live birth or stillbirth. Births refer to the individual
newborn; for example, a twin delivery represents two births.
Multiple gestation A pregnancy with more than one embryo or fetus.
Natural cycle ART An ART procedure in which one or more oocytes are collected from the ovaries during a menstrual cycle
without the use of any pharmacological compound.
Necrozoospermia The description of an ejaculate in which no live spermatozoa can be found.
Neonatal death/mortality Death of a live born baby within 28 days of birth. This can be sub-divided into a) early, if death occurs in
the ﬁrst 7 days after birth; and b) late, if death occurs between 8 and 28 days after birth.
Neonatal mortality rate Number of neonatal deaths (up to 28 days) per 1000 live births.
Neonatal period The period which commences at birth and ends at 28 completed days after birth.
Non-obstructive azoospermia Absence of spermatozoa in the ejaculate due to lack of production of mature spermatozoa.
Nuclear maturation The process during which the oocyte resumes meiosis and progresses from prophase I to metaphase II.
Obstructive azoospermia Absence of spermatozoa in the ejaculate due to occlusion of the ductal system.
Oligospermia A term for low semen volume now replaced by hypospermia to avoid confusion with oligozoospermia.
Oligozoospermia Low concentration of spermatozoa in the ejaculate below the lower reference limit. When reporting
results, the reference criteria should be speciﬁed.
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Oocyte The female gamete (egg).
Oocyte aspiration Ovarian follicular aspiration performed with the aim of retrieving oocytes.
Oocyte bank Repository of cryopreserved oocytes stored for future use.
Oocyte donation The use of oocytes from an egg donor for reproductive purposes or research.
Oocyte donation cycle An ART cycle in which oocytes are collected from an egg donor for reproductive purposes or research.
Oocyte cryopreservation The freezing or vitriﬁcation of oocytes for future use.
Oocyte maturation triggering An intervention intended to induce an oocyte in vitro or in vivo to resume meiosis to reach maturity (i.e.
to reach metaphase II).
Oocyte recipient cycle An ART cycle in which a woman receives oocytes from a donor, or her partner if in a same sex
relationship, to be used for reproductive purposes.
Oolemma The cytoplasmic membrane enclosing the oocyte.
Ooplasm The cytoplasm of the oocyte.
Ovarian hyperstimulation syndrome (OHSS) An exaggerated systemic response to ovarian stimulation characterized by a wide spectrum of clinical and
laboratory manifestations. It may be classiﬁed as mild, moderate or severe according to the degree of
abdominal distention, ovarian enlargement and respiratory, hemodynamic and metabolic complications.
Ovarian reserve A term generally used to indicate the number and/or quality of oocytes, reﬂecting the ability to
reproduce. Ovarian reserve can be assessed by any of several means. They include: female age; number
of antral follicles on ultrasound; anti-Mullerian hormone levels; follicle stimulating hormone and estradiol
levels; clomiphene citrate challenge test; response to gonadotropin stimulation, and oocyte and/or
embryo assessment during an ART procedure, based on number, morphology or genetic assessment of
the oocytes and/or embryos.
Ovarian stimulation (OS) Pharmacological treatment with the intention of inducing the development of ovarian follicles. It can be
used for two purposes: 1) for timed intercourse or insemination; 2) in ART, to obtain multiple oocytes at
follicular aspiration.
Ovarian tissue cryopreservation The process of slow-freezing or vitriﬁcation of tissue surgically excised from the ovary with the intention
of preserving reproductive capacity.
Ovarian torsion Partial or complete rotation of the ovarian vascular pedicle that causes obstruction to ovarian blood ﬂow,
potentially leading to necrosis of ovarian tissue.
Ovulation The natural process of expulsion of a mature egg from its ovarian follicle.
Ovulation induction (OI) Pharmacological treatment of women with anovulation or oligo-ovulation with the intention of inducing
normal ovulatory cycles.
Parthenogenetic activation The process by which an oocyte is activated to undergo development in the absence of fertilization.
Parthenote The product of an oocyte that has undergone activation in the absence of the paternal genome, with
(induced) or without (spontaneous) a purposeful intervention.
Percutaneous epididymal sperm aspiration (PESA) A surgical procedure in which a needle is introduced percutaneously into the epididymis with the
intention of obtaining sperm.
Perinatal death/mortality Fetal or neonatal death occurring during late pregnancy (at 22 completed weeks of gestational age and
later), during childbirth, or up to seven completed days after birth.
Perinatal mortality rate The number of perinatal deaths per 1000 total births (stillbirths plus live births).
Period total fertility rate (PTFR) The estimated average number of live born children per woman that would be born to a cohort of
women throughout their reproductive years, if the fertility rates by age in a given period remained
constant at the current age-speciﬁc fertility rate.
Perivitelline space The space between the cytoplasmic membrane enclosing the oocyte and the innermost layer of the zona
pellucida. (This space may contain the ﬁrst and second polar bodies and extracellular fragments.)
Pituitary down-regulation A medical or pharmacological method to prevent the release of gonadotropins (FSH, LH) from the
pituitary gland.
Polar bodies The small bodies containing chromosomes segregated from the oocyte by asymmetric division during
telophase. The ﬁrst polar body is extruded at telophase I and normally contains only chromosomes with
duplicated chromatids (2c); the second polar body is extruded in response to fertilization or in response
to parthenogenetic activation and normally contains chromosomes comprising single chromatids (1c).
Polycystic ovary syndrome (PCOS) A heterogeneous condition, which requires the presence of two of the following three criteria: (1) Oligo-
ovulation or anovulation; (2) Hyperandrogenism (clinical evidence of hirsutism, acne, alopecia and/or
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biochemical hyperandrogenemia); (3) Polycystic ovaries, as assessed by ultrasound scan with more than
24 total antral follicles (2–9 mm in size) in both ovaries.
Polycystic ovary (PCO) An ovary with at least 12 follicles measuring 2–9 mm in diameter in at least one ovary (Rotterdam
criteria). PCO may be present in women with PCOS, but also in women with normal ovulatory function
and normal fertility.
Polyploidy The condition in which a cell has more than two haploid sets of chromosomes: e.g. a triploid embryo has
three sets of chromosomes and a tetraploid embryo has four sets. Polyploidy in a human embryo is not
compatible with life.
Polyspermy The process by which an oocyte is penetrated by more than one spermatozoon.
Poor ovarian responder (POR) in assisted
reproductive technology
A woman treated with ovarian stimulation for ART, in which at least two of the following features are
present: (1) Advanced maternal age (≥40 years); (2) A previous poor ovarian response (≤3 oocytes with
a conventional stimulation protocol aimed at obtaining more than three oocytes); and, (3) An abnormal
ovarian reserve test (i.e. antral follicle count 5–7 follicles or anti-Mullerian hormone 0.5–1.1 ng/ml
(Bologna criteria); or other reference values obtained from a standardized reference population.)
Poor ovarian response (POR) to ovarian
stimulation
A condition in which fewer than four follicles and/or oocytes are developed/obtained following ovarian
stimulation with the intention of obtaining more follicles and oocytes.
Post-implantation embryo An embryo at a stage of development beyond attachment to the endometrium to eight completed weeks
after fertilization, which is equivalent to 10 weeks of gestational age.
Post-term birth A live birth or stillbirth that takes place after 42 completed weeks of gestational age.
Posthumous reproduction A process utilizing gametes and/or embryos from a deceased person or persons with the intention of
producing offspring.
Pregnancy A state of reproduction beginning with implantation of an embryo in a woman and ending with the
complete expulsion and/or extraction of all products of implantation.
Pregnancy loss The outcome of any pregnancy that does not result in at least one live birth. When reporting pregnancy
loss, the estimated gestational age at the end of pregnancy should be recorded.
Pregnancy of unknown location (PUL) A pregnancy documented by a positive human chorionic gonadotropin (hCG) test without visualization of
pregnancy by ultrasound. This condition exists only after circulating hCG concentration is compatible
with ultrasound visualization of a gestational sac.
Pre-implantation embryo An embryo at a stage of development beginning with division of the zygote into two cells and ending just
prior to implantation into a uterus.
Preimplantation genetic testing (PGT) A test performed to analyze the DNA from oocytes (polar bodies) or embryos (cleavage stage or
blastocyst) for HLA-typing or for determining genetic abnormalities. These include: PGT for aneuploidies
(PGT-A); PGT for monogenic/single gene defects (PGT-M); and PGT for chromosomal structural
rearrangements (PGT-SR).
Preimplantation genetic diagnosis (PGD) and
screening (PGS)
These terms have now been replaced by preimplantation genetic testing PGT. (See term PGT and its
deﬁnitions.)
Premature ejaculation A condition in which semen is released sooner than desired.
Premature ovarian insufﬁciency A condition characterized by hypergonadotropic hypogonadism in women younger than age 40 years
(also known as premature or primary ovarian failure). It includes women with premature menopause.
Preterm birth A birth that takes place after 22 weeks and before 37 completed weeks of gestational age.
Primary childlessness A condition in which a person has never delivered a live child, or has never been a legal or societally-
recognized parent to a child.
Primary female infertility A woman who has never been diagnosed with a clinical pregnancy and meets the criteria of being
classiﬁed as having infertility.
Primary involuntary childlessness A condition in a person with a child wish, who has never delivered a live child, or has never been a legal
or societally-recognized parent to a child. A major cause of primary involuntary childlessness is infertility.
Primary male infertility A man who has never initiated a clinical pregnancy and meets the criteria of being classiﬁed as infertile.
Pronuclei transfer Transfer of the pronuclei from a patient’s zygote to an enucleated donated zygote.
Pronucleus A round structure in the oocyte surrounded by a membrane containing chromatin. Normally, two
pronuclei are seen after fertilization, each containing a haploid set of chromosomes, one set from the
oocyte and one from the sperm, before zygote formation.
Recipient (ART) A person or couple who receives donated eggs, sperm or embryos for the purposes of initiating a
pregnancy with the intention of becoming a legally recognized parent.
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Recipient ART cycle An ART cycle in which a woman receives zygote(s) or embryo(s) from donor(s) or a partner.
Recurrent spontaneous abortion/miscarriage The spontaneous loss of two or more clinical pregnancies prior to 22 completed weeks of gestational
age.
Reproductive surgery Surgical procedures performed to diagnose, conserve, correct and/or improve reproductive function in
either men or women. Surgery for contraceptive purposes, such as tubal ligation and vasectomy, are also
included within this term.
Retrograde ejaculation A condition that causes the semen to be forced backward from the ejaculatory ducts into the bladder
during ejaculation.
Salpingectomy The surgical removal of an entire Fallopian tube.
Salpingitis isthmica nodosa (SIN) A nodular thickening of the proximal Fallopian tube (where the tubes join the uterus), which can distort
or occlude the tubes and increase the risk of ectopic pregnancy and infertility.
Salpingostomy A surgical procedure in which an opening is made in the Fallopian tube either to remove an ectopic
pregnancy or open a blocked ﬂuid-ﬁlled tube (hydrosalpinx).
Secondary female infertility A woman unable to establish a clinical pregnancy but who has previously been diagnosed with a clinical
pregnancy.
Secondary involuntary childlessness A condition in a person with a child wish, who has previously delivered a live child, or is or has been a
legal or societally-recognized parent to a child. A major cause of secondary involuntary childlessness is
infertility.
Secondary male infertility A man who is unable to initiate a clinical pregnancy, but who had previously initiated a clinical pregnancy.
Semen analysis A description of the ejaculate to assess function of the male reproductive tract. Characteristic
parameters include volume, pH, concentration, motility, vitality, morphology of spermatozoa and
presence of other cells.
Semen liquefaction The process whereby proteolytic enzymes degrade proteins causing seminal plasma to liquefy.
Semen viscosity The description of the relative ﬂuidity of seminal plasma.
Semen volume The amount of ﬂuid in an ejaculate.
Semen/Ejaculate The ﬂuid at ejaculation that contains the cells and secretions originating from the testes and sex accessory
glands.
Seminal plasma The ﬂuids of the ejaculate.
Sertoli cell The non-germinal cell type in the seminiferous tubule that mediates the actions of testosterone and FSH
in the testis, provides nutrients and proteins to the developing spermatogenic cells, creates the blood-
testis barrier, and secretes Mullerian-inhibiting hormone.
Sertoli cell-only syndrome A condition in which only Sertoli cells line the seminiferous tubules with usually a complete absence of germ
cells; also referred to as germ cell aplasia. Spermatogenesis in isolated foci can be observed in rare cases.
Severe ovarian hyperstimulation syndrome
(OHSS)
A systemic response as a result of ovarian stimulation interventions that is characterized by severe
abdominal discomfort and/or other symptoms of ascites, hemoconcentration (Hct > 45) and/or other
serious biochemical abnormalities requiring hospitalization for observation and/or for medical
intervention (paracentesis, other).
Single embryo transfer (SET) The transfer of one embryo in an ART procedure. Deﬁned as elective (eSET) when more than one
embryo of sufﬁcient quality for transfer is available.
Slow-freezing A cryopreservation procedure in which the temperature of the cell(s) is lowered in a step-wise fashion,
typically using a computer controlled rate, from physiological (or room) temperature to extreme low
temperature.
Small for gestational age A birth weight less than the 10th centile for gestational age. When reporting results the reference criteria
should be speciﬁed. If gestational age is unknown, the birth weight should be registered.
Sperm bank Repository of cryopreserved sperm stored for future use.
Sperm concentration The (measure of the) number of spermatozoa in millions per 1 ml of semen.
Sperm density A measure of the mass/volume ratio (speciﬁc gravity) for spermatozoa.
Sperm isolation A procedure that involves the separation of sperm through centrifugation and resuspension in culture
media. It can be used to remove seminal plasma and infectious agents before IUI and ART procedures.
This procedure has been shown to be effective in the removal of HIV. It may also be effective in removing
other infectious particles but clinical safety and efﬁcacy have to be established for each particular
infection. This term is sometimes referred to as ‘sperm washing’.
Sperm motility The percentage of moving spermatozoa relative to the total number of spermatozoa.
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Sperm recipient cycle A MAR cycle in which a woman receives spermatozoa from a person who is not her sexually intimate
partner. In the case of ART registry data, a sperm recipient cycle would only include data from cycles
using ART procedures.
Sperm vitality The percentage of live spermatozoa relative to the total number of spermatozoa.
Spermatogenic arrest Failure of germ cells to progress through speciﬁc stages of spermatogenesis at onset or during meiosis.
Spermatozoon The mature male reproductive cell produced in the testis that has the capacity to fertilize an oocyte. A head
carries genetic material, a midpiece produces energy for movement, and a long, thin tail propels the sperm.
Spontaneous abortion/miscarriage The spontaneous loss of an intra-uterine pregnancy prior to 22 completed weeks of gestational age.
Spontaneous reduction/vanishing sac(s) The spontaneous disappearance of one or more gestational sacs with or without an embryo or fetus in a
multiple pregnancy documented by ultrasound.
Sterility A permanent state of infertility.
Stillbirth The death of a fetus prior to the complete expulsion or extraction from its mother after 28 completed
weeks of gestational age. The death is determined by the fact that, after such separation, the fetus does
not breathe or show any other evidence of life, such as heartbeat, umbilical cord pulsation, or deﬁnite
movement of voluntary muscles. Note: It includes deaths occurring during labor.
Stillbirth rate The number of stillbirths per 1000 total births (stillbirths plus live births).
Subfertility A term that should be used interchangeably with infertility.
Syngamy The process during which the female and male pronuclei fuse.
Teratozoospermia A reduced percentage of morphologically normal sperm in the ejaculate below the lower reference limits.
When reporting results, the reference criteria should be speciﬁed.
Testicular sperm aspiration/extraction (TESA/
TESE)
A surgical procedure involving one or more testicular biopsies or needle aspirations to obtain sperm for
use in IVF and/or ICSI.
Thawing The process of raising the temperature of slow-frozen cell(s) from the storage temperature to room/
physiological temperature.
Time to pregnancy (TTP) The time taken to establish a pregnancy, measured in months or in numbers of menstrual cycles.
Time-lapse imaging The photographic recording of microscope image sequences at regular intervals in ART, referring to
gametes, zygotes, cleavage-stage embryos or blastocysts.
Total delivery rate with at least one live birth The total number of deliveries with at least one live birth resulting from one initiated or aspirated ART
cycle, including all cycles in which fresh and/or frozen embryos are transferred, including more than one
delivery from one initiated or aspirated cycle if that occurs, until all embryos are used. Notes: The
delivery of a singleton, twin or other multiple pregnancy is registered as one delivery. In the absence of
complete data, the total delivery rate is often estimated.
Total fertility rate (TFR) The average number of live births per woman. It may be determined in retrospect, observed data (Cohort
Total Fertility Rate, CTFR) or as an estimated average number (Period Total Fertility Rate, PTFR).
Total sperm count The calculated total number of sperm in the ejaculate (semen volume multiplied by the sperm
concentration determined from an aliquot of semen).
Traditional gestational carrier A woman who donates her oocytes and is the gestational carrier for a pregnancy resulting from
fertilization of her oocytes either through an ART procedure or insemination. This replaces the term
‘traditional surrogate.’
Trisomy An abnormal number of chromosome copies in a cell characterized by the presence of three
homologous chromosomes rather than the normal two. The majority of human embryos with trisomies
are incompatible with life.
Trophectoderm Cells forming the outer layer of a blastocyst that have the potential to develop into the placenta and
amniotic membranes.
Tubal pathology Tubal abnormality resulting in dysfunction of the Fallopian tube, including partial or total obstruction of
one or both tubes (proximally, distally or combined), hydrosalpinx and/or peri-tubal and/or peri-ovarian
adhesions affecting the normal ovum pick-up function. It usually occurs after pelvic inﬂammatory disease
or pelvic surgery.
Unexplained infertility Infertility in couples with apparently normal ovarian function, Fallopian tubes, uterus, cervix and pelvis
and with adequate coital frequency; and apparently normal testicular function, genito-urinary anatomy
and a normal ejaculate. The potential for this diagnosis is dependent upon the methodologies used and/
or those methodologies available.
Unisomy The condition in a cell resulting from loss of a single chromosome yielding a single copy of that particular
chromosome rather than the normal two. The majority of unisomies in human embryos are incompatible
with life.
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Vaginal insemination A procedure whereby semen, collected from a non-lubricated condom or similar method, is deposited
into the vaginal cavity of a female. An intervention that can be self-administered by a woman attempting
pregnancy.
Varicocele A venous enlargement in the testicular pampiniform plexus.
Varicocelectomy Procedure to occlude or remove part of the internal spermatic vein in situations in which it has expanded
into a varicocele.
Vasectomy Procedure to occlude the vas deferens. It is usually carried out bilaterally in order to secure sterilization.
Very low birth weight Birth weight less than 1500 g.
Viscosity The description of the relative ﬂuidity of the semen.
Vitriﬁcation An ultra-rapid cryopreservation procedure that prevents ice formation within a cell whose aqueous
phase is converted to a glass-like solid.
Voluntary childlessness A condition describing a person who does not have or has not had a child wish and does not have any
biologically, legally or societally-recognized children.
Warming (cells) The process of raising the temperature of a vitriﬁed cell or cells from the storage temperature to room/
physiological temperature.
Y-chromosome microdeletions Missing segments of the genetic material on the Y-chromosome that are associated with abnormal
spermatogenesis.
Zona pellucida The glycoprotein coat surrounding the oocyte.
Zygote A single cell resulting from fertilization of a mature oocyte by a spermatozoon and before completion of
the ﬁrst mitotic division.
Zygote intrafallopian transfer (ZIFT) An ART procedure in which one or more zygotes is transferred into the Fallopian tube.
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